




Searching News Database: NP-1
HSMN NewsFeed - 15 Dec 2010
EpiCept Announces Initiation by NCI of Phase II Trial with Crolibulin(TM) in Anaplastic Thyroid Cancer
EpiCept Announces Initiation by NCI of Phase II Trial with Crolibulin(TM) in Anaplastic Thyroid Cancer
HSMN NewsFeed - 28 Jul 2010
EpiCept Amends Employment Agreement and Completes Severance Agreements with Executive Officers
EpiCept Amends Employment Agreement and Completes Severance Agreements with Executive Officers
HSMN NewsFeed - 11 Jan 2010
EpiCept Announces Commercial Licensing Agreement for Ceplene(R) with Meda in Europe and Pacific Rim
EpiCept Announces Commercial Licensing Agreement for Ceplene(R) with Meda in Europe and Pacific Rim
HSMN NewsFeed - 6 Nov 2009
EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
HSMN NewsFeed - 27 May 2008
EpiCept Files Re-Examination Documentation for Marketing Authorization of Ceplene(TM) in Europe
EpiCept Files Re-Examination Documentation for Marketing Authorization of Ceplene(TM) in Europe
HSMN NewsFeed - 27 Feb 2008
EpiCept Announces Non-Binding Opinion by European Regulatory Authority on Ceplene Marketing Application
EpiCept Announces Non-Binding Opinion by European Regulatory Authority on Ceplene Marketing Application
HSMN NewsFeed - 7 Feb 2008
EpiCept Announces Encouraging Results of Phase II Trial for NP-1 Cream in Diabetic Peripheral Neuropathy
EpiCept Announces Encouraging Results of Phase II Trial for NP-1 Cream in Diabetic Peripheral Neuropathy
HSMN NewsFeed - 19 Jul 2007
EpiCept Establishes Direct Licensing Agreement with Dalhousie University for EpiCept(TM) NP-1
EpiCept Establishes Direct Licensing Agreement with Dalhousie University for EpiCept(TM) NP-1
Additional items found! 2

Members Archive contains
2 additional stories matching:
NP-1
(Password required)
NP-1
(Password required)